Evidence map›Paper›PMID 33515103›Full record

ArticleMetabolomics : Official journal of the Metabolomic Society2021

A non-targeted LC-MS metabolic profiling of pregnancy: longitudinal evidence from healthy and pre-eclamptic pregnancies.

Tiina Jääskeläinen, Olli Kärkkäinen, Jenna Jokkala, Anton Klåvus, Seppo Heinonen, Seppo Auriola, Marko Lehtonen, FINNPEC Core Investigator Group, Kati Hanhineva, Hannele Laivuori

Abstract read
In one paragraph

Article in Metabolomics : Official journal of the Metabolomic Society, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed.

  1. Observational
  2. Article
  3. Subtype specific immune-metabolic reprogramming in preeclampsia revealed by multiomics and serum biomarkers.Hypertension research : official journal of the Japanese Society of Hypertension · 2026
    Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Metabolic profiles of meconium in preeclamptic and normotensive pregnancies.Metabolomics : Official journal of the Metabolomic Society · 2025
    Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Review
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Tiina JääskeläinenMedical and Clinical Genetics, University of Helsinki and Helsinki University Hospital, Helsinki, Finland. tiina.j.jaaskelainen@helsinki.fi.ORCID http://orcid.org/0000-0002-1202-0936
Olli KärkkäinenInstitute of Public Health and Clinical Nutrition, University of Eastern Finland, Kuopio, Finland.ORCID http://orcid.org/0000-0003-0825-4956
Jenna JokkalaInstitute of Public Health and Clinical Nutrition, University of Eastern Finland, Kuopio, Finland.
Anton KlåvusInstitute of Public Health and Clinical Nutrition, University of Eastern Finland, Kuopio, Finland.
Seppo HeinonenObstetrics and Gynecology, University of Helsinki and Helsinki University Hospital, Helsinki, Finland.
Seppo AuriolaSchool of Pharmacy, University of Eastern Finland, Kuopio, Finland.
Marko LehtonenSchool of Pharmacy, University of Eastern Finland, Kuopio, Finland.
FINNPEC Core Investigator Group
Kati HanhinevaInstitute of Public Health and Clinical Nutrition, University of Eastern Finland, Kuopio, Finland.
Hannele LaivuoriMedical and Clinical Genetics, University of Helsinki and Helsinki University Hospital, Helsinki, Finland.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionMaternal metabolism changes substantially during pregnancy. However, few studies have used metabolomics technologies to characterize changes across gestation. OBJECTIVES AND

methodsWe applied liquid chromatography-mass spectrometry (LC-MS) based non-targeted metabolomics to determine whether the metabolic profile of serum differs throughout the pregnancy between pre-eclamptic and healthy women in the FINNPEC (Finnish Genetics of Preeclampsia Consortium) Study. Serum samples were available from early and late pregnancy.

resultsProgression of pregnancy had large-scale effects to the serum metabolite profile. Altogether 50 identified metabolites increased and 49 metabolites decreased when samples of early pregnancy were compared to samples of late pregnancy. The metabolic signatures of pregnancy were largely shared in pre-eclamptic and healthy women, only urea, monoacylglyceride 18:1 and glycerophosphocholine were identified to be increased in the pre-eclamptic women when compared to healthy controls.

conclusionsOur study highlights the need of large-scale longitudinal metabolomic studies in non-complicated pregnancies before more detailed understanding of metabolism in adverse outcomes could be provided. Our findings are one of the first steps for a broader metabolic understanding of the physiological changes caused by pregnancy per se.

Indexed as

AdultBody Mass IndexCase-Control StudiesChromatography, LiquidFemaleHumansMetabolomeMetabolomicsPre-EclampsiaPregnancyTandem Mass SpectrometryLC–MSMetabolomicsPreeclampsiaPregnancy

Identifiers

PMID33515103
PMCPMC7846510

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.